NASH
Showing 1 - 25 of 1,247
Non-alcoholic Fatty Liver Disease Trial (GSK4532990)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease
- (no location specified)
Oct 23, 2023
Non-alcoholic Steatohepatitis Trial (INI-822 (A), Placebo (B))
Not yet recruiting
- Non-alcoholic Steatohepatitis
- INI-822 (A)
- Placebo (B)
- (no location specified)
Jul 6, 2023
Non-Alcoholic Steatohepatitis (NASH) Trial in Fort Myers, Sarasota (Pemvidutide, Placebo)
Recruiting
- Non-Alcoholic Steatohepatitis (NASH)
- Pemvidutide
- Placebo
-
Fort Myers, Florida
- +1 more
Aug 10, 2023
NASH Trial in Karachi (Misoprostol, Placebo)
Completed
- NASH
- Misoprostol
- Placebo
-
Karachi, Sindh, PakistanDr. Ziauddin Hospital Clifton
Mar 26, 2023
NASH, NAFLD, NASH With Fibrosis Trial
Not yet recruiting
- NASH
- +8 more
- (no location specified)
Dec 13, 2022
NASH, NAFLD Trial in Hangzhou (GH509, Placebo)
Recruiting
- NASH
- NAFLD
- GH509
- Placebo
-
Hangzhou, Zhejiang, ChinaThe Affiliated Hospital of Hangzhou Normal University
Mar 26, 2023
Nonalcoholic Steatohepatitis (NASH) Trial in Guangzhou (ZSP1601, Placebo)
Not yet recruiting
- Nonalcoholic Steatohepatitis (NASH)
- ZSP1601
- Placebo
-
Guangzhou, ChinaNanFang Hospital
Jan 10, 2023
Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)
Not yet recruiting
- Nonalcoholic Steatohepatitis (NASH)
- ASC41 2 mg
- +2 more
- (no location specified)
Jan 30, 2023
NAFLD, NASH - Nonalcoholic Steatohepatitis, HIV Trial in Indianapolis, Boston (Vitamin E, Placebos)
Active, not recruiting
- NAFLD
- +2 more
- Vitamin E
- Placebos
-
Indianapolis, Indiana
- +1 more
Feb 1, 2023
Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)
Not yet recruiting
- Nonalcoholic Steatohepatitis (NASH)
- ADI-PEG20
- Placebo
-
Kaohsiung, Taiwan
- +4 more
Apr 24, 2023
NASH - Nonalcoholic Steatohepatitis Trial in Durham (Atorvastatin (40 mg daily), Placebo)
Not yet recruiting
- NASH - Nonalcoholic Steatohepatitis
- Atorvastatin
- Placebo
-
Rochester, Minnesota
- +1 more
Dec 21, 2022
Nonalcoholic Steatohepatitis (NASH) Trial (CS0159 (Linafexor))
Not yet recruiting
- Nonalcoholic Steatohepatitis (NASH)
- CS0159 (Linafexor)
- (no location specified)
Nov 14, 2022
NAFLD, NASH - Nonalcoholic Steatohepatitis, Obesity, Morbid Trial in Rotterdam (NASH screening, Cardiac dysfunction screening,
Not yet recruiting
- NAFLD
- +2 more
- NASH screening
- +2 more
-
Rotterdam, Zuid Holland, NetherlandsFranciscus Gasthuis
Aug 11, 2022
NASH - Nonalcoholic Steatohepatitis Trial in San Francisco (Spironolactone 100mg, Placebo oral capsule)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- Spironolactone 100mg
- Placebo oral capsule
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 9, 2022
Liver Diseases, Blood Disorder, Digestive System Disease Trial in Hershey (Aerobic Exercise)
Completed
- Liver Diseases
- +2 more
- Aerobic Exercise
-
Hershey, PennsylvaniaPenn State Hershey Medical Center
Jan 31, 2023
NASH, Cirrhosis, Liver Trial in North Little Rock (Resmetirom)
Not yet recruiting
- NASH
- Cirrhosis, Liver
-
North Little Rock, ArkansasArkansas Gastroenterology
Aug 11, 2022
Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD) Trial in Boston
Recruiting
- Non-alcoholic Steatohepatitis (NASH)
- +6 more
- Insulin Resistance
- +4 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 19, 2022
"LLIFT",Novel Non-invasive Biomarker for Diagnosis of Non
Recruiting
- Obesity
- NASH - Nonalcoholic Steatohepatitis
-
Amiens, France
- +6 more
Jan 26, 2023
Nonalcoholic Steatohepatitis (NASH) Trial in Gent (ORMD-0801 QD, ORMD-0801 BD)
Completed
- Nonalcoholic Steatohepatitis (NASH)
- ORMD-0801 QD
- ORMD-0801 BD
-
Gent, BelgiumUniversitaire Ziekenhuis Gent
Sep 15, 2022
NASH With Fibrosis Trial in Beijing
Not yet recruiting
- NASH With Fibrosis
-
Beijing, Beijing, ChinaBeijing Tsinghua Changgung Hospital
Nov 3, 2023
Psoriasis and Non Alcoholic Steatohepatitis: Is ThereShared
Not yet recruiting
- Nash
- (no location specified)
Aug 15, 2023
NASH With Fibrosis Trial (rencofilstat, 75 mg, rencofilstat, 150mg, rencofilstat, 225 mg)
Not yet recruiting
- NASH With Fibrosis
- rencofilstat, 75 mg
- +2 more
- (no location specified)
Jul 13, 2022
Non-alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Trial in Chandler, Peoria
Completed
- Non-alcoholic Steatohepatitis
- +2 more
- BT-NCBT-00X
-
Chandler, Arizona
- +1 more
Dec 12, 2022
NASH - Nonalcoholic Steatohepatitis Trial in Boston (Estradiol patch, Placebo)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- Estradiol patch
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Apr 8, 2022
Liver Diseases, Liver Cirrhosis, NASH - Nonalcoholic Steatohepatitis Trial (Ultrasound liver assessment)
Not yet recruiting
- Liver Diseases
- +5 more
- Ultrasound liver assessment
- (no location specified)
Aug 22, 2022